Aeolus Pharmaceuticl Stock Analysis
| AOLS Stock | USD 0.0001 0.00 0.00% |
Aeolus Pharmaceuticl is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Aeolus Pharmaceuticl pink sheet analysis is to determine its intrinsic value, which is an estimate of what Aeolus Pharmaceuticl is worth, separate from its market price. There are two main types of Aeolus Pharmaceuticl's stock analysis: fundamental analysis and technical analysis.
The Aeolus Pharmaceuticl pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Aeolus |
Aeolus Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aeolus Pharmaceuticl recorded a loss per share of 0.03. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 16th of July 2004. Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Aeolus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for Aeolus Pharmaceuticl is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Aeolus Pharmaceuticl please contact John McManus at 949-481-9825 or go to https://www.aeoluspharma.com.Aeolus Pharmaceuticl Investment Alerts
| Aeolus Pharmaceuticl generated a negative expected return over the last 90 days | |
| Aeolus Pharmaceuticl has some characteristics of a very speculative penny stock | |
| Aeolus Pharmaceuticl has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.08 M. Net Loss for the year was (3.56 M) with loss before overhead, payroll, taxes, and interest of (805 K). | |
| Aeolus Pharmaceuticl currently holds about 403 K in cash with (3.11 M) of positive cash flow from operations. |
Aeolus Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 167.29 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aeolus Pharmaceuticl's market, we take the total number of its shares issued and multiply it by Aeolus Pharmaceuticl's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Aeolus Pharmaceuticl technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Aeolus Pharmaceuticl Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Aeolus Pharmaceuticl middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Aeolus Pharmaceuticl. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Aeolus Pharmaceuticl Outstanding Bonds
Aeolus Pharmaceuticl issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aeolus Pharmaceuticl uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aeolus bonds can be classified according to their maturity, which is the date when Aeolus Pharmaceuticl has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
About Aeolus Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Aeolus Pharmaceuticl prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aeolus shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Aeolus Pharmaceuticl. By using and applying Aeolus Pink Sheet analysis, traders can create a robust methodology for identifying Aeolus entry and exit points for their positions.
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Aeolus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Aeolus Pharmaceuticl to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Additional Tools for Aeolus Pink Sheet Analysis
When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.